In Brief: Interleukin interference?
Executive Summary
Interleukin interference?: Roche's IL-12 is being studied in clinical trials for advanced kidney cancer at Sloan-Kettering and the Cleveland Clinic, company says. Interleukin-12 was misidentified as interferon by "The Pink Sheet" in a story published June 19 ("The Pink Sheet" June 19, T&G-7)...